Amgen Inc. v. Sanofi: Does the Supreme Court's Call for the Solicitor General's Views Signal an Intention to Resolve Important Enablement Questions for Genus Claims?
Is the genus claim dead, or has its demise been greatly exaggerated? We may soon have the Supreme Court’s answer. On April 18, following eight years…